Susquehanna International Group, LLP Scopus Bio Pharma Inc. Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.36 - $0.74 $7,460 - $15,335	-20,723 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.6 - $1.7 $12,433 - $35,229	20,723 New	20,723 $14,000
Q2 2021 Aug 11, 2021	SELL	$5.17 - $10.25 $76,510 - $151,689	-14,799 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.94 - $14.87 $117,504 - $220,061	14,799 New	14,799 $125,000

Ticker SCPS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,094,300
Description
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.